Int Immunopharmacol
June 2025
Recent studies have showed that 5-methylcytosine (m5C) can be utilized to assess the prognosis of tumors. However, the role of clinical implications of m5C modification remains unclear. The mRNA expression profiles and clinical features were downed from GEO and ICGC databases.
View Article and Find Full Text PDF